(Q44871715)

7 December 2017

title

Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy (English)

1 reference

7 December 2017

6

1 reference

7 December 2017

1

Dieter Flesch-Janys

1 reference

7 December 2017

11

Jenny Chang-Claude

1 reference

7 December 2017

5

Nadia Obi

1 reference

7 December 2017

2

Tracy Slanger

1 reference

7 December 2017

3

Elke Mutschelknauss

1 reference

7 December 2017

4

Silke Kropp

1 reference

7 December 2017

7

Wilhelm Braendle

1 reference

7 December 2017

Gunter Bastert

8

1 reference

7 December 2017

Stefan Hentschel

series ordinal

9

1 reference

7 December 2017

Jürgen Berger

series ordinal

10

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 August 2008

1 reference

International Journal of Cancer

7 December 2017

published in

1 reference

7 December 2017

volume

123

1 reference

7 December 2017

issue

4

1 reference

7 December 2017

page(s)

933-941

1 reference

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

7 December 2017

cites work

1 reference

Breast cancer and hormone-replacement therapy: the Million Women Study

21 January 2018

1 reference

An overview of menopausal oestrogen-progestin hormone therapy and breast cancer risk

21 January 2018

1 reference

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

21 January 2018

1 reference

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

21 January 2018

1 reference

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma

21 January 2018

1 reference

Relationship between long durations and different regimens of hormone therapy and risk of breast cancer

21 January 2018

1 reference

Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States)

21 January 2018

1 reference

Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis

21 January 2018

1 reference

Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study

21 January 2018

1 reference

Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe

21 January 2018

1 reference

A prospective study of different types of hormone replacement therapy use and the risk of subsequent breast cancer: the women's health in the Lund area (WHILA) study (Sweden)

21 January 2018

1 reference

Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study

21 January 2018

1 reference

Problems involved in including women with simple hysterectomy in epidemiologic studies measuring the effects of hormone replacement therapy on breast cancer risk

21 January 2018

1 reference

A comparison of different methods for including 'age at menopause' in analyses of the association between hormone replacement therapy use and breast cancer

21 January 2018

1 reference

Test-retest reliability of self-reported reproductive and lifestyle data in the context of a German case-control study on breast cancer and postmenopausal hormone therapy

21 January 2018

1 reference

Good agreement between physician and self-reported hormone therapy data in a case-control study

21 January 2018

1 reference

Breast cell proliferation in postmenopausal women during HRT evaluated through fine needle aspiration cytology.

21 January 2018

1 reference

Norgestrel and gestodene stimulate breast cancer cell growth through an oestrogen receptor mediated mechanism

21 January 2018

1 reference

Nomegestrol acetate, a clinically useful 19-norprogesterone derivative which lacks estrogenic activity

21 January 2018

1 reference

Exogenous progestagens and the human breast

21 January 2018

1 reference

Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study

21 January 2018

1 reference

Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones

21 January 2018

1 reference

Breast cancer risk factors and mammographic breast density in women over age 70.

21 January 2018

1 reference

Estimating blood volume in obese and morbidly obese patients

21 January 2018

1 reference

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.23655

1 reference

7 December 2017

1 reference